Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference
REDWOOD CITY, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq:SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming J.P. Morgan 42nd Annual Health Care Conference in San Francisco, CA.
Related news for (SEER)
- Galorath Launches SEERai: The First Estimation-Centric Agentic Artificial Intelligence Platform for Cost, Schedule, and Risk Operational Intelligence
- Seer’s Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults
- Seer Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook
- SpaceWorks Enterprises Inc. Integrates AI into Spaceflight Planning and National Defense Initiatives with SEERai, Galorath’s AI-Powered Cost Estimation Platform
- Veracyte Announces Decipher Prostate Genomic Classifier Results are Linked to Real-World Data in National Cancer Institute’s SEER Specialized Database Release